European stock indices edge lower, led by U.K. shares amid disappointing earnings reports and accelerating consumer price growth. Fund manager pressure mounts on the board of Britain’s No. 2 drugs maker AstraZeneca to entertain a thrice-sweetened $117 billion bid from pharmaceuticals giant Pfizer following a statement from Schroders, while FTSE 100 stalwarts Vodafone Group, the telecom, and variety-store retailer Marks & Spencer both decline after reporting full-year earnings figures. Vodafone says investment will rein in profit in the current year and Marks & Spencer fails to wow shareholders with upbeat commentary on the margin outlook.

If you liked this article you might like

Wall Street Overlooks Trump's North Korea Threats to Hit New Records

Stocks on Track for Records Even as Trump Goes After North Korea

T-Mobile, Sprint Deal Talk Lead Telecom Stocks to Post Big Gains

T-Mobile US, Vodafone Group, Dollar Tree: 'Mad Money' Lightning Round

Bears Are Looming Over Amazon: Cramer's 'Mad Money' Recap (Wed 8/23/17)